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Abstract: Carbon monoxide (CO) has been reported to contribute to the maintenance of gastric
mucosal integrity, gastroprotection, and ulcer healing. However, involvement of transient receptor
potential vanilloid receptor type 1 (TRPV1) located on afferent sensory fibers endings and sensory
neuropeptide calcitonin gene-related peptide (CGRP) in CO-mediated gastroprotection against
ethanol-induced gastric damage has not been explored. Male Wistar rats with and without
denervation of afferent sensory neurons induced by capsaicin (total dose 125 mg/kg within
3 days) were pretreated with vehicle, CO donor tricarbonyldichlororuthenium (II) dimer (CORM-2,
5 mg/kg i.g.), administered alone or with CGRP-α (10 µg/kg i.p.) or TRPV1 antagonist capsazepine
(5 mg/kg i.g.), followed 30 min later by intragastric (i.g.) administration of 75% ethanol. The area of
gastric damage and gastric blood flow (GBF) were assessed planimetrically and by laser flowmetry,
respectively. Microscopic evaluation of ethanol-induced gastric lesions was performed after
haematoxylin/eosin (H&E) or alcian blue/periodic acid-Schiff/alcian blue (AB/PAS) staining. Gastric
mucosal mRNA fold change for heme oxygenase (HMOX)-1, HMOX-2, CGRP-α, CGRP-β, inducible
nitric oxide synthase (iNOS), endothelial (e)NOS, neuronal (n)NOS, cyclooxygenase (COX)-1, COX-2,
and protein expression for HMOX-1 and TRPV1 was determined by real-time PCR or Western blot,
respectively. Pretreatment with CORM-2 combined or not with CGRP reduced ethanol-induced
gastric lesions and elevated GBF. Capsaicin-denervation or co-treatment with capsazepine or CGRP
and CORM-2 in capsaicin-denervated animals failed to affect these beneficial effects of CO donor.
In rats with intact sensory nerves, CORM-2 increased gastric mRNA level for HMOX-1 and CGRP-α.
In capsaicin-denervated rats, CORM-2 increased eNOS mRNA fold change and TRPV1 protein
expression while capsaicin denervation itself decreased HMOX-1 protein expression and eNOS
mRNA level. We conclude that CO prevents gastric mucosa from ethanol-induced lesions due to
activation of TRPV1/CGRP-α system and accompanying increase in gastric microcirculation but
independently on afferent sensory nerve activity despite the stimulation of TRPV1 protein and
CGRP-α mRNA expression.
Keywords: carbon monoxide; gastric mucosa; transient receptor potential vanilloid receptor type 1;
calcitonin gene-related peptide
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1. Introduction
Gastric mucosal integrity is maintained by the activity of various physiological factors such as
endogenous prostaglandins, nitric oxide (NO), hydrogen sulfide (H2S), and mechanisms such as mucus
producing and bicarbonates secreting epithelial cells, gastric microcirculation, and expression and
activity of scavengers of reactive oxygen species (ROS) [1–3]. However, necrotizing agents i.e., ethyl
alcohol, drugs such as non-steroid anti-inflammatory drugs (NSAIDs) (e.g., aspirin) or stress are
considered as the major factors responsible for the disruption of gastric mucosal barrier causing a fall
in the gastric blood flow (GBF) and an impairment of protective lines of mucosal defense system [4,5].
Gastric microcirculation is regulated by the activity of afferent sensory neurons, known to release
the vasoactive mediator calcitonin gene-related peptide (CGRP) through the activation of transient
receptor potential vanilloid receptor type 1 (TRPV1) at the site of inflammation [6–8].
Besides NO and H2S, carbon monoxide (CO) has also recently been reported to play an essential role
in the maintenance of gastric mucosal integrity due to its anti-inflammatory and vasoactive properties
involved in the regulation of GBF [9–11]. Recently our group reported that gaseous mediators NO, H2S,
and CO, exhibited gastroprotective activity but in contrast to NO and H2S, the CO-induced protection
was found to be independent on the activity of afferent sensory neurons [8,11]. However, the contribution
of TRPV1 and CGRP to CO-mediated gastroprotection against ethanol-induced gastric lesions has not
been fully investigated and needs further evaluation.
Therefore, in this study we aimed to evaluate if CO released from its pharmacological donor,
tricarbonyldichlororuthenium (II) dimer (CORM-2) can prevent the rat gastric mucosa against
ethanol-induced gastric damage in TRPV1/CGRP-dependent manner. We also determined the
alterations in gastric mucosal mRNA, protein expression, or both, for (a) enzymes involved in
endogenous CO production, heme oxygenase (HMOX)-1, and HMOX-2 [8], (b) key enzymes of
endogenous prostaglandin biosynthesis, cyclooxygenase (COX)-1, and COX-2 [8], and (c) crucial
enzymes responsible for production of endogenous NO, constitutive endothelial NOS (eNOS) and
neuronal NOS (nNOS), and inducible NO synthase (iNOS) [8,11] in CORM-2 pretreated rats with
intact or capsaicin-denervated sensory nerves receiving 75% ethanol.
2. Results
Figure 1 shows that pretreatment with CORM-2 (5 mg/kg i.g.) administered alone or in
combination with CGRP-α (10 µg/kg i.p.) significantly decreased the mean area of ethanol-induced
gastric damage and significantly increased GBF as compared with vehicle-pretreated control group
of rats with and without capsaicin denervation of afferent sensory neurons (p < 0.05) (Figure 1A,B).
This observation partly confirmed our previously published evidence that CORM-2 prevented
ethanol-induced gastric damage and that this effect was accompanied by an increase in GBF [12].
ZnPP administered to rats with capsaicin denervation did not significantly affect ethanol-induced
damage area or GBF (Figure 1A,B). Capsaicin denervation itself significantly increased the area of
gastric damage induced by ethanol and significantly decreased GBF as compared with vehicle-control
group without capsaicin-sensory nerves ablation (p < 0.05) (Figure 1A,B).
Int. J. Mol. Sci. 2018, 19, 2960 3 of 15
Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  3 of 16 
 
 
  
Figure 1. Mean area of 75% ethanol‐induced gastric damage (A) and gastric blood flow (GBF) (B) in 
rats with or without afferent sensory neurons ablation (capsaicin denervation) and pretreated with 
vehicle, CORM‐2 (5 mg/kg i.g.), ZnPP (5 mg/kg i.g.) alone or in combination with CGRP‐α (10 µg/kg 
i.p.). Intact refers to healthy gastric mucosa, not exposed to 75% ethanol. Results are mean ± SEM of 
4–5 rats per each experimental group. (A) Significant change as compared with the respective values 
in vehicle‐control group without capsaicin denervation was indicated by asterisk or cross (p < 0.05); 
double crosses indicate significant changes compared to the values obtained in the vehicle‐pretreated 
group with capsaicin denervation (p < 0.05); (B) Significant change as compared with the respective 
values in intact gastric mucosa was indicated by asterisk (p < 0.05); double asterisks indicate 
significant changes compared to the values obtained in the vehicle‐pretreated group without 
capsaicin denervation (p < 0.05); cross indicates a significant change as compared with the respective 
vehicle‐pretreated and capsaicin‐denervated animals (p < 0.05); double crosses indicate significant 
changes compared to the values obtained in the vehicle‐pretreated group with capsaicin denervation 
(p < 0.05). 
The microscopic appearance of intact gastric mucosa and gastric injury in rats administered with 
75% ethanol is shown in Figure 2(A1–E2). Figure 2(A1) shows representative histology 
photomicrographs of intact gastric mucosa stained with H&E and AB/PAS (Figure 2(A1,A2), 
respectively) and vehicle‐control gastric mucosa treated with 75% ethanol (Figure 2(B1,B2)). In rats 
pretreated with vehicle with or without capsaicin denervation, administration of 75% ethanol 
resulted in necrotic erosions deeply penetrating into gastric mucosa with significant leukocytes 
infiltration into submucosal layer with accompanying extensive desquamation of epithelium surface 
(Figure 2(B1,D1) vs. Figure 2(A1)). Mucus layer on the surface of the gastric mucosa was completely 
reduced and glycoprotein content was intense in submucosal part exposed to 75% ethanol as 
observed in AB/PAS staining and compared with histological appearance of intact healthy gastric 
mucosa (Figure 2(B2,D2) vs. Figure 2(A2)). Increased glycoproteins production was observed in 
healthy gastric mucosa surrounding necrotic ethanol‐induced damage (Figure 2(B2,D2)). 
In gastric mucosa of rats with or without capsaicin denervation and pretreated with CORM‐2, 
ethanol‐induced epithelial damage was limited only to superficial layer and less white blood cells 
infiltration was observed as compared with vehicle‐control samples (Figure 2(C1,E1) vs. Figure 
2(B1,D1), respectively). However, disrupted by ethanol continuity of mucosal lining and mucus layer 
was not completely preserved in rats pretreated with CORM‐2 with and without sensory nerves 
ablation as compared to vehicle‐control (Figure 2(C2,E2) vs. Figure 2(B2,D2), respectively). 
Figure 1. Mean area of 75% ethanol-induced gastric damage (A) and gastric blood flow (GBF) (B) in rats
with or without afferent sensory neurons ablation (capsaicin denervation) and pretreated with vehicle,
CORM-2 (5 mg/kg i.g.), ZnPP (5 mg/kg i.g.) alone or in combination with CGRP-α (10 µg/kg i.p.).
Intact refers to healthy gastric mucosa, not exposed to 75% ethanol. Results are mean ± SEM of
4–5 rats per each experimental group. (A) Significant change as compared with the respective values
in vehicle-control group without capsaicin denervation was indicated by asterisk or cross (p < 0.05);
double crosses indicate significant changes compared to the values obtained in the vehicle-pretreated
group with capsaicin denervation (p < 0.05); (B) Significant change as compared with the respective
values in intact gastric mucosa was indicated by asterisk (p < 0.05); double asterisks indicate significant
changes compared to the values obtained in the vehicle-pretreated group without capsaicin denervation
(p < 0.05); cross indicates a significant change as compared with the respective vehicle-pretreated and
capsaicin-denervated animals (p < 0.05); double crosses indicate significant changes compared to the
values obtained in the vehicle-pretreated group with capsaicin denervation (p < 0.05).
The microscopic appearance of intact gastric mucosa and gastric injury in rats administered
with 75% ethanol is shown in Figure 2(A1–E2). Figure 2(A1) shows representative histology
photomicrographs of intact gastric mucosa stained with H&E and AB/PAS (Figure 2(A1,A2),
respectively) and vehicle-control gastric mucosa treated with 75% ethanol (Figure 2(B1,B2)). In rats
pretreated with vehicle with or without capsaicin denervation, administration of 75% ethanol resulted
in necrotic erosions deeply penetrating into gastric mucosa with significant leukocytes infiltration into
submucosal layer with accompanying extensive desquamation of epithelium surface (Figure 2(B1,D1)
vs. Figure 2(A1)). Mucus layer on the surface of the gastric mucosa was completely reduced and
glycoprotein content was intense in submucosal part exposed to 75% ethanol as observed in AB/PAS
staining and compared with histological appearance of intact healthy gastric mucosa (Figure 2(B2,D2)
vs. Figure 2(A2)). Increased glycoproteins production was observed in healthy gastric mucosa
surrounding necrotic ethanol-induced damage (Figure 2(B2,D2)).
In gastric mucosa of rats with or without capsaicin denervation and pretreated with CORM-2,
ethanol-induced epithelial damage was limited only to superficial layer and less white blood
cells infiltration was observed as compared with vehicle-control samples (Figure 2(C1,E1) vs.
Figure 2(B1,D1), respectively). However, disrupted by ethanol continuity of mucosal lining and
mucus layer was not completely preserved in rats pretreated with CORM-2 with and without sensory
nerves ablation as compared to vehicle-control (Figure 2(C2,E2) vs. Figure 2(B2,D2), respectively).
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Figure 2. Microscopic appearances of H&E (A1–E1) or AB/PAS (A2–E2) stained intact gastric mucosa 
and gastric mucosa of rats with or without capsaicin denervation, exposed to 75% ethanol and 
pretreated with vehicle or CORM‐2 (5 mg/kg i.g.). 
Capsazepine (5 mg/kg i.g.) failed to affect CORM‐2‐induced decrease in the area of ethanol‐
induced gastric lesions and the increase in GBF as compared with the respective values in rats 
pretreated with CORM‐2 alone (Figure 3A,B).  
Figure 2. Microscopic appearances of H&E (A1–E1) or AB/ AS (A2–E2) stained intact gastric mucosa
and gastric mucosa of rats with or without capsaicin denervation, exposed to 75% ethanol and
pretreated with vehicle or CORM-2 (5 mg/kg i.g.).
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Capsazepine (5 mg/kg i.g.) failed to affect CORM-2-induced decrease in the area of ethanol-induced
gastric lesions and the increase in GBF as compared with the respective values in rats pretreated with
CORM-2 alone (Figure 3A,B).Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  5 of 16 
 
 
Figure 3. Mean area of 75% ethanol‐induced gastric damage (A) and GBF (B) in rats pretreated with 
vehicle or CORM‐2 (5 mg/kg i.g.) alone or in combination with capsazepine (5 mg/kg i.g.). Intact refers 
to healthy gastric mucosa, not exposed to 75% ethanol. Results are mean ± SEM of 4–5 rats per each 
experimental group. (A) Significant change as compared with the respective values in vehicle‐control 
group was indicated by asterisk (p < 0.05); (B) Significant change as compared with the respective 
values in intact gastric mucosa was indicated by asterisk (p < 0.05); cross indicates significant change 
compared to the values obtained in the vehicle pretreated group (p < 0.05). 
Figure 4 shows that protein expression for TRPV1 is significantly increased in gastric mucosa 
administered with 75% ethanol as compared with intact rats (p < 0.05). Pretreatment with CORM‐2 (5 
mg/kg i.g.) significantly upregulated TRPV1 protein expression as compared with vehicle‐control 
group (p < 0.05) (Figure 4). After administration of 75% ethanol to vehicle pretreated rats with 
capsaicin denervation, the expression of gastric mucosal TRPV1 protein was significantly increased 
as compared with gastric mucosa administered with 75% ethanol in rats with intact sensory nerves 
(p < 0.05) (Figure 4). Pretreatment with CORM‐2 failed to affect TRPV1 protein expression as 
compared with vehicle‐control group of rats with capsaicin denervation and administered with 75% 
ethanol (Figure 4).   
Figure 3. Mean area of 75% ethanol-induced gastric damage (A) and GBF (B) in rats pretreated with
vehicle or CORM-2 (5 mg/kg i.g.) alone or in combination with capsazepine (5 mg/kg i.g.). Intact refers
to h althy gastric mucosa, not exp sed to 75% etha ol. Results are mean ± SEM of 4–5 rats per each
experimental group. (A) Significant change as comp red with the respective values in vehicle-control
group was indicated by asterisk (p < 0.05); (B) Significant change as compar d with the r spective
values in intact gastric mucosa was indicated by asterisk (p < 0.05); cross indicates significant change
compared to the values obtained in the vehicle pretreated group (p < 0.05).
Figure 4 shows that protein expression for TRPV1 is significantly increased in gastric mucosa
administered with 75% ethanol as compared with intact rats (p < 0.05). Pretreatment with CORM-2
(5 mg/kg i.g.) significantly upregulated TRPV1 protein expression as compared with vehicle-control
group (p < 0.05) (Figure 4). After administration of 75% ethanol to vehicle pretreated rats with capsaicin
denervation, the expression of gastric mucosal TRPV1 protein was significantly increased as compared
with gastric mucosa administered with 75% ethanol in rats with intact sensory nerves (p < 0.05)
(Figure 4). Pretreatment with CORM-2 ailed to affe t TRPV1 protein expression as compared with
vehicle-control group of rats with c psaicin denervation and admi istered with 75% ethanol (Figure 4).
Figure 5A shows tha CGRP-α mRNA fold change in gastric mucosa of vehicle-pretr ated rats
administered with 75% ethanol was not significantly affected as compared with respective values in
intact gastric mucosa. Pretreatment with CORM-2 significantly increased the mRNA fold change for
CGRP-α as compared with respective vehicle-control group in rats without capsaicin denervation
(p < 0.05) but not in those with capsaicin-induced sensory denervation (Figure 5A). In gastric mucosa
of rats with capsaicin denervation, CGRP-α mRNA fold change was not significantly affected as
compared with vehicle-control group with intact sensory nerves (Figure 5A). Figure 5B shows that
CGRP-β mRNA fold change in gastric mucosa pretreated with vehicle and administered with 75%
ethanol was significantly decreased as compared with respective values in intact gastric mucosa and
this fall in fold change of CGRP-β mRNA remained without significant change in capsaicin denervated
animals with or without CORM-2 combined or not with CGRP.
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Figure 4. Protein expression of TRPV1 in gastric mucosa of rats pretreated with vehicle or CORM‐2 
(5 mg/kg i.g.) and administered i.g. with 75% ethanol with or without capsaicin denervation. Intact 
refers to healthy gastric mucosa. Results are expressed as protein expressions of TRPV1 normalized 
to β‐actin. Results are mean ± SEM of 4–5 rats per group. Asterisk indicates a significant change as 
compared with values obtained in intact gastric mucosa (p < 0.05). Double asterisks or cross indicates 
significant change as compared with respective values obtained in vehicle‐pretreated group without 
capsaicin denervation (p < 0.05). 
Figure 5A shows that CGRP‐α mRNA fold change in gastric mucosa of vehicle‐pretreated rats 
administered with 75% ethanol was not significantly affected as compared with respective values in 
intact gastric mucosa. Pretreatment with CORM‐2 significantly increased the mRNA fold change for 
CGRP‐α as compared with respective vehicle‐control group in rats without capsaicin denervation (p 
< 0.05) but not in those with capsaicin‐induced sensory denervation (Figure 5A). In gastric mucosa of 
rats with capsaicin denervation, CGRP‐α mRNA fold change was not significantly affected as 
compared with vehicle‐control group with intact sensory nerves (Figure 5A). Figure 5B shows that 
CGRP‐β mRNA fold change in gastric mucosa pretreated with vehicle and administered with 75% 
ethanol was significantly decreased as compared with respective values in intact gastric mucosa and 
this fall in fold change of CGRP‐β mRNA remained without significant change in capsaicin 
denervated animals with or without CORM‐2 combined or not with CGRP. 
Figure 4. Protein expression of TRPV1 in gastric mucosa of rats pretreated with vehicle or CORM-2
(5 mg/kg i.g.) and administered i.g. with 75% ethanol with or without capsaicin denervation. Intact
refers to healthy gastric mucosa. Results are expressed as protein expressions of TRPV1 normalized
to β-actin. Results are mean ± SEM of 4–5 rats er group. Asterisk indicates a significant change as
c mpared with values obt ined in intact gastric mucosa (p < 0.05). Double asterisks or cross indicates
significant change as compar with respective value obtained in vehicle-pr treated g up without
capsai in denervation (p < 0.05).
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Figure 5. CGRP‐α (A) and CGRP‐β (B) mRNA fold change in gastric mucosa of rats with or without 
capsaicin denervation and pretreated with vehicle, CORM‐2 (5 mg/kg i.g.) alone or in combination 
with exogenous CGRP‐α (10 µg/kg i.p.) and administered i.g. with 75% ethanol. Intact refers to 
healthy gastric mucosa. Results are expressed as mRNA fold change of CGRP‐α or CGRP‐β 
normalized to succinate dehydrogenase complex, subunit A (SDHA) and β‐actin. Results are mean ± 
SEM. of 4–5 rats per group. (A) Asterisk indicates a significant change as compared with vehicle‐
control group without capsaicin denervation (p < 0.05); cross indicates a significant change as 
compared with the group treated with CORM‐2 without capsaicin‐denervation. (B) Asterisk indicates 
significant change as compared with values obtained in intact gastric mucosa (p < 0.05). 
Figure 6A,B show mRNA fold change for HMOX‐1 and HMOX‐2, respectively, in rats pretreated 
with vehicle or CORM‐2 (5 mg/kg i.g.) with and without capsaicin denervation and followed by i.g. 
application of 75% ethanol. In gastric mucosa of vehicle‐control rats administered with ethanol with 
and without capsaicin denervation, HMOX‐1 mRNA fold change was significantly increased as 
compared with intact rats (p < 0.05) (Figure 6A). Pretreatment with CORM‐2 alone or combined with 
CGRP‐α a further upregulation of this fold change was observed as compared to vehicle‐control 
groups with and without capsaicin denervation (p < 0.05) (Figure 6A). These observations partly 
confirm our previously published results that 75% ethanol upregulated gastric mucosal HMOX‐1 
mRNA fold change and pretreatment with CORM‐2 enhanced this effect [12]. In gastric mucosa of 
rats with capsaicin denervation who received ethanol, HMOX‐1 mRNA fold change was not 
significantly affected as compared with vehicle‐control group with intact sensory nerves (Figure 6A). 
Gastric mucosal HMOX‐2 mRNA fold change was not significantly affected by 75% ethanol neither 
in rats without nor with capsaicin denervation (Figure 6B). Figure 6C shows that HMOX‐1 protein 
expression was significantly downregulated in gastric mucosa exposed to 75% ethanol in vehicle‐
control rats with capsaicin denervation as compared with animals without sensory denervation 
administered with ethanol (p < 0.05). 
Figure 5. CGRP-α (A) and CGRP-β (B) mRNA fold change in gastric mucosa of rats with or without
capsaicin denervation and pretreated with vehicle, CORM-2 (5 mg/kg i.g.) alone or in combination
with exogenous CGRP-α (10 µg/kg i.p.) and administered i.g. with 75% ethanol. Intact refers to healthy
gastric mucosa. Results are expressed as mRNA fold change of CGRP-α or CGRP-β normalized to
succinate dehydrogenase complex, subunit A (SDHA) and β-actin. Results are mean ± SEM. of 4–5 rats
per group. (A) Asterisk indicates a significant change as compared with vehicle-control group without
capsaicin denervation (p < 0.05); cross indicates a significant change as compared with the group treated
with CORM-2 without capsaicin-denervation. (B) Asterisk indicates significant change as compared
with values obtained in intact gastric mucosa (p < 0.05).
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Figure 6A,B show mRNA fold change for HMOX-1 and HMOX-2, respectively, in rats pretreated
with vehicle or CORM-2 (5 mg/kg i.g.) with and without capsaicin denervation and followed by i.g.
application of 75% ethanol. In gastric mucosa of vehicle-control rats administered with ethanol with and
without capsaicin denervation, HMOX-1 mRNA fold change was significantly increased as compared with
intact rats (p < 0.05) (Figure 6A). Pretreatment with CORM-2 alone or combined with CGRP-α a further
upregulation of this fold change was observed as compared to vehicle-control groups with and without
capsaicin denervation (p < 0.05) (Figure 6A). These observations partly confirm our previously published
results that 75% ethanol upregulated gastric mucosal HMOX-1 mRNA fold change and pretreatment with
CORM-2 enhanced this effect [12]. In gastric mucosa of rats with capsaicin denervation who received
ethanol, HMOX-1 mRNA fold change was not significantly affected as compared with vehicle-control
group with intact sensory nerves (Figure 6A). Gastric mucosal HMOX-2 mRNA fold change was not
significantly affected by 75% ethanol neither in rats without nor with capsaicin denervation (Figure 6B).
Figure 6C shows that HMOX-1 protein expression was significantly downregulated in gastric mucosa
exposed to 75% ethanol in vehicle-control rats with capsaicin denervation as compared with animals
without sensory denervation administered with ethanol (p < 0.05).
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Figure 6. HMOX‐1 (A) and HMOX‐2 (B) mRNA fold change in gastric mucosa of rats with or without 
capsaicin denervation and pretreated with vehicle or CORM‐2 (5 mg/kg i.g.) alone or with CGRP‐α 
(10 µg/kg i.p.) followed by i.g. administration of 75% ethanol. Panel C: gastric mucosal HMOX‐1 
protein expression in rats administered with 75% ethanol with and without capsaicin denervation. 
Results are expressed as mRNA fold change of HMOX‐1 and HMOX‐2 normalized to succinate 
dehydrogenase complex, subunit A (SDHA) and β‐actin. Results are mean ± SEM of 4–5 rats per each 
experimental group. (A) Asterisk indicates a significant change as compared with intact rats (p < 0.05); 
double asterisks indicate significant difference as compared with vehicle pretreated group without 
capsaicin denervation (p < 0.05); cross indicates significant change as compared with vehicle 
pretreated group with capsaicin denervation (p < 0.05). (C) Asterisk indicates significant change as 
compared with gastric mucosa administered with 75% ethanol of rats without capsaicin denervation 
(p < 0.05). 
Gastric mucosal COX‐1 mRNA fold change in vehicle‐control rats was not significantly affected 
by the application of 75% ethanol neither in rats without nor with capsaicin denervation (Figure 7A). 
In gastric mucosa of rats with and without capsaicin denervation and with ethanol‐induced gastric 
damage, COX‐2 mRNA fold change was significantly increased as compared with intact rats (p < 0.05) 
(Figure 7B). Pretreatment with CORM‐2 administered alone or combined with CGRP‐α significantly 
decreased this COX‐2 mRNA fold change as compared to respective vehicle‐control groups with and 
without capsaicin denervation (p < 0.05) (Figure 7B). 
Figure 6. HMOX-1 (A) and HMOX-2 (B) mRNA fold change in gastric mucosa of rats with or without
capsaicin denervation and pretreated with vehicle or CORM-2 (5 mg/kg i.g.) alone or with CGRP-α
(10 µg/kg i.p.) followed by i.g. administration of 75% ethanol. Panel C: gastric mucosal HMOX-1
protein expression in rats administered with 75% ethanol with and without capsaicin denervation.
Results are expressed as mRNA fold change of HMOX-1 and HMOX-2 normalized to succinate
dehydrogenase complex, subunit A (SDHA) and β-actin. Results are mean ± SEM of 4–5 rats per each
experimental group. (A) Asterisk indicates a significant change as co pared with intact rats (p < 0.05);
double asterisks indicate significant difference as compared with vehicle pretreated group without
capsaicin denervation (p < 0.05); cross indicates significant change as compared with vehicle pretreated
group with capsaicin denervation (p < 0.05). (C) Asterisk indicates significant change as compared
with gastric m cosa administered with 75% ethanol of rats without capsaicin denervation (p < 0.05).
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Gastric mucosal COX-1 mRNA fold change in vehicle-control rats was not significantly affected
by the application of 75% ethanol neither in rats without nor with capsaicin denervation (Figure 7A).
In gastric mucosa of rats with and without capsaicin denervation and with ethanol-induced gastric
damage, COX-2 mRNA fold change was significantly increased as compared with intact rats (p < 0.05)
(Figure 7B). Pretreatment with CORM-2 administered alone or combined with CGRP-α significantly
decreased this COX-2 mRNA fold change as compared to respective vehicle-control groups with and
without capsaicin denervation (p < 0.05) (Figure 7B).Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  9 of 16 
 
 
 
Figure 7. COX‐1 (A) and COX‐2 (B) mRNA fold change in gastric mucosa of rats pretreated with 
vehicle or CORM‐2 (5 mg/kg i.g.) alone or with CGRP‐α (10 µg/kg i.p.) followed by i.g. administration 
of 75% ethanol with or without capsaicin denervation. Results are expressed as mRNA fold change 
of COX‐1 and COX‐2 normalized to succinate dehydrogenase complex, subunit A (SDHA) and β‐
actin. Results are mean ± SEM of 4–5 rats per each experimental group. Asterisk indicates significant 
change as compared with intact rats (p < 0.05); double asterisks indicate significant difference as 
compared with vehicle‐pretreated group without capsaicin denervation (p < 0.05); cross indicates 
significant change as compared with vehicle‐pretreated group with capsaicin denervation (p < 0.05). 
In gastric mucosa of rats with and without capsaicin denervation and with ethanol‐induced 
gastric damage, iNOS mRNA fold change was significantly increased as compared with intact rats (p 
< 0.05) (Figure 8A). Pretreatment with CORM‐2 administered alone or combined with CGRP‐α 
downregulated this expression as compared to respective vehicle‐control groups with and without 
capsaicin denervation (p < 0.05) (Figure 8A). Gastric mucosal eNOS mRNA fold change was 
upregulated by 75% ethanol in rats without capsaicin denervation (p < 0.05) (Figure 8B). Pretreatment 
with CORM‐2 administered alone or combined with CGRP‐α significantly decreased this expression 
as compared to vehicle‐control group without capsaicin denervation (p < 0.05) (Figure 8B). In 
capsaicin denervated animals, 75% ethanol downregulated gastric mucosal eNOS mRNA fold change 
as compared with vehicle‐pretreated control group administered with 75% ethanol without sensory 
denervation (p < 0.05) (Figure 8B). Pretreatment with CORM‐2 administered alone or combined with 
CGRP‐α significantly increased eNOS mRNA fold change as compared to vehicle‐pretreated rats 
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Figure 7. COX-1 (A) and COX-2 (B) mRNA fold change in gastric mucosa of rats pretreated with
vehicle or CORM-2 (5 mg/kg i.g.) alone or with CGRP-α (10 µg/kg i.p.) followed by i.g. administration
of 75% ethanol with or without capsaicin denervation. Results are expressed as mRNA fold change of
COX-1 and COX-2 normalized to succinate dehydrogenase complex, subunit A (SDHA) and β-actin.
Results are mean ± SEM of 4–5 rats per each experimental group. Asterisk indicates significant change
as compared with intact rats (p < 0.05); double asterisks indicate significant difference as compared with
vehicle-pretreated group without capsaicin denervation (p < 0.05); cross indicates significant change as
compared with vehicle-pretreated group with capsaicin denervation (p < 0.05).
In gastric mucosa of rats with and without capsaicin denervation and with ethanol-induced
gastric damage, iNOS mRNA fold change was significantly increased as compared with intact rats
(p < 0.05) (Figure 8A). Pretreatment with CORM-2 administered alone or combined with CGRP-α
downregulated this expression as compared to respective vehicle-control groups with and without
capsaicin denervation (p < 0.05) (Figure 8A). Gastric mucosal eNOS mRNA fold change was
upregulated by 75% ethanol in rats without capsaicin denervation (p < 0.05) (Figure 8B). Pretreatment
with CORM-2 administered alone or combined with CGRP-α significantly decreased this expression
as compared to vehicle-control group without capsaicin denervation (p < 0.05) (Figure 8B). In capsaicin
denervated animals, 75% ethanol downregulated gastric mucosal eNOS mRNA fold change as
compared with vehicle-pretreated control group administered with 75% ethanol without sensory
denervation (p < 0.05) (Figure 8B). Pretreatment with CORM-2 administered alone or combined with
CGRP-α significantly increased eNOS mRNA fold change as compared to vehicle-pretreated rats
with capsaicin denervation exposed to 75% ethanol (p < 0.05) (Figure 8B). Pretreatment with CORM-2
administered alone or combined with CGRP-α significantly increased nNOS mRNA fold change as
compared to vehicle-pretreated rats without capsaicin denervation exposed to 75% ethanol (p < 0.05)
(Figure 8C).
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Figure 8. iNOS (A), eNOS (B), and nNOS (C) mRNA fold change in gastric mucosa of rats with or
without capsaicin denervation and pretreated with vehicle or CORM-2 (5 mg/kg i.g.) alone or with
CGRP-α (10 µg/kg i.p.) followed by i.g. administration of 75% ethanol. Results are expressed as mRNA
fold change of iNOS, eNOS, and nNOS normalized to succinate dehydrogenase complex, subunit A
(SDHA) and β-actin. Results are mean ± SEM of 4–5 rats per each experimental group. (A) Asterisk
indicates significant change as compared with intact rats (p < 0.05); double asterisks indicate significant
difference as compared with vehicle pretreated group without capsaicin denervation (p < 0.05); cross
indicates significant change as compared with vehicle pretreated group with capsaicin denervation
(p < 0.05); (B) Asterisk indicates significant change as compared with intact rats (p < 0.05); double
asterisks indicate significant difference as compared with vehicle pretreated group without capsaicin
denervation (p < 0.05); cross indicates significant change as compared with vehicle pretreated group
without capsaicin denervation (p < 0.05); double crosses indicate significant difference as compared
with vehicle pretreated group with capsaicin denervation (p < 0.05); (C) Asterisk indicates significant
change as compared with intact rats (p < 0.05); double asterisks or cross indicates significant difference
as compared with vehicle pretreated group without capsaicin denervation (p < 0.05).
3. Discussion
Afferent sensory C neuronal fibers play an important role in regulation of gastric microcirculation
and therefore in the maintenance of gastric mucosal integrity by the mechanism involving release of
vasoactive CGRP due to activation of TRPV1 [6,7,11,13]. Interestingly, endogenous gaseous mediators
NO, H2S, and CO have been shown to increase GBF and prevent gastric mucosa from the formation
of acute gastric mucosal lesions induced by intragastric application of aspirin, ethanol, strong acid
and bases, or exposure of experimental animals to cold stress [8,11,12]. Moreover, the cross-talk
between NO or H2S and afferent sensory nerves activity is considered to be essential element for
the functionality of gastric mucosal barrier [11]. Previously, we have demonstrated that locally
increased bioavailability of CO prevented gastric mucosa against ethanol-induced necrotic damage
and that this effect was accompanied by the enhancement in GBF [12]. This observation has been
confirmed also in other studies showing that CO prevents gastric mucosa against necrotic damage
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by its interaction with 5’ adenosine monophosphate-activated protein kinase [14]. However, the
interaction of neuromediator released from afferent C fiber endings with gaseous molecule CO in the
pathogenesis of ethanol-induced gastric damage still remains unexplored.
To our best knowledge we provided for the first time the experimental evidence that mechanism
of gastroprotective effect of CO released from its pharmacological donor, CORM-2 against necrotic
ethanol-induced gastric damage involves the upregulation of TRPV1 protein expression in gastric
mucosa. First of all, we have observed that application of 75% ethanol dramatically decreased GBF and
that this effect coincides with an increase in gastric mucosal protein expression of TRPV1. In contrast,
the gastroprotective effect of CORM-2 was accompanied by elevation of GBF and enhancement of
this TRPV1 expression suggesting that CO exerts the gastroprotective activity due to its vasoactive
properties possibly mediated by the CO-induced stimulation of vanilloid receptors located at afferent
sensory nerves. Further support for this notion that the afferent sensory nerves can be involved
in CORM-2-induced gastroprotection against ethanol damage comes out from our observation that
CORM-2 increased mRNA fold change for CGRP-α, the neuropeptide released from afferent nerve
endings which is known to act through TRPV1 to exert its gastroprotective and vasorelaxatory activities
including an increase in GBF. Interestingly, besides the originally discovered localization at intrinsic
enteric neurons and extrinsic sensory neurons, TRPV1 has also been identified in epithelial and
endocrine cells [15]. Moreover, the co-localization of immunoreactive CGRP released from afferent
neurons with TRPV1 receptors has been documented throughout the gastrointestinal tract including
stomach [16]. Besides the enhancement in gastric microcirculation, the beneficial effects of CGRP
on gastric mucosa include inhibition of gastric acid secretion, prevention of cellular apoptosis and
the attenuation of oxidative injury [17]. Furthermore, the agonists of TRPV1 were reported to exert
considerable potential for gastric mucosal protection [17].
However, the concominant treatment of CORM-2 with exogenous CGRP-α failed to considerably
enhance the genuine gastroprotective effects of CO donor when administered alone against
ethanol-induced damage and the accompanying gastric hyperemia observed in CORM-2 pretreated
animals. This is in keeping with previously published observation on CO and CGRP relationship
demonstrating that the pharmacological inhibition of HMOX-1 which decreased production of
endogenous CO also downregulated CGRP-α mRNA expression in dorsal root ganglia [18].
Moreover, it has been shown in other systems that the increased CGRP concentration and expression
HMOX-1 protein were correlated in patients with Barrter/Gitelman syndromes [19]. We assume that
ethanol-induced damage and immunity changes associated with this inflammatory signaling could
activate a self-defense response of gastric mucosa as reflected by the increased TRPV1 protein expression.
Furthermore, CO released from CORM-2 applied prior ethanol enhanced this beneficial mucosal
response possibly by a physiological feedback mechanism resulting in acceleration of this effect of
CORM-2 on CGRP-α fold change in a consequence leading to vasodilatation, elevation of GBF and
finally attenuating the severity of ethanol-induced gastric damage.
On the other hand, capsaicin denervation of afferent sensory neurons or pharmacological
inhibition of TRPV1 by capsazepine failed to reduce gastroprotective and vasodilatory effect of CO
released from CORM-2 in gastric mucosa compromised by ethanol. This is in pair with previously
published data showing that capsaicin denervation failed to affect gastroprotective effect of CO against
aspirin- or stress-induced gastric lesions [8,11]. Moreover, the CO-mediated decrease of gastric mucosal
mRNA fold change of proinflammatory COX-2 and iNOS was not affected in ethanol-treated rats
with capsaicin-induced sensory denervation. Interestingly, we observed that the gastric mucosal
protein or mRNA expression of HMOX-1 and eNOS, key enzymes responsible for the production
of endogenous CO or NO production, respectively, were both decreased in gastric mucosa of rats
with capsaicin-induced denervation of afferent sensory neurons and reversed CORM-2-induced
upregulation of CGRP-α mRNA expression. Furthermore, pharmacological inhibition of HMOX-1
by ZnPP did not affected ethanol-induced gastric damage or GBF. Similarly, Peng et al. reported
that high dose of capsaicin abrogated HMOX-1 expression in dorsal root ganglia and therefore
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enhanced monophosphoryl lipid A (MLA)-induced delayed cardioprotection [20]. On the other
hand, activation of TRPV1 by low doses of capsaicin increased mRNA expression for HMOX-1 and
ameliorated cisplatin-induced nephrotoxicity [21]. Additionally, TRPV1 agonist, glyceryl nonivamide
upregulated HMOX-1 expression and inhibited lipopolysaccharide-activated microglia-mediated
neuronal death [22]. We assume, that in our ethanol model, the decreased content of endogenous
CO and NO as a result of capsaicin denervation weakened gastric mucosal barrier and therefore
potentiated ethanol-induced gastric damage formation. Because CORM-2 increased gastric mucosal
eNOS mRNA fold change in rats with sensory neurons ablation and nNOS mRNA fold change in rats
with intact sensory fibers, we conclude that the CO-mediated gastroprotection and vasorelaxation
under these conditions with depletion of sensory neuropeptides, mainly CGRP, could involve increased
bioavailability of NO despite the suppression of sensory nerve activity by capsaicin. Indeed, in our
previous studies we have observed that CO gastroprotection against ethanol-induced gastric damage is
reduced when NOS activity was pharmacologically inhibited [12]. We assume that capsaicin-induced
aggravation of ethanol-induced gastric damage is due to decreased HMOX-1 activity. We conclude
that it is also possible that exogenous CO directly acts on gastric microcirculation and increases blood
flow by its vasodilatory effect, rather than mediated by afferent nerve activation via TRPV1 and CGRP
since CORM-2 increased eNOS expression under capsaicin denervation. Therefore, exogenous CO
may increase blood flow directly or via nitric oxide (NO) production from eNOS and nNOS.
4. Materials and Methods
4.1. Experimental Design: Animals, Chemicals, and Drugs Treatment Regime
Fifty male Wistar rats 8–9 weeks old and weighting 220–300 g were fasted for 24 h with free access
to drinking water before all chemicals and drugs application. All rats were fed with standard food
and water under the environment with temperature 20 ± 2 ◦C, humidity 50–60% and 12 h light/dark
cycle. The study was approved by the Institutional Animal Care and Use Committee of Jagiellonian
University Medical College in Cracow (Approval no 68/2014, permission date: 21 May 2014; Approval
no 137/2012, permission date: 19 September 2012) and run in accordance with the statements of
the Helsinki Declaration regarding handling of experimental animals. Experiments were run with
implications for replacement, refinement or reduction (the 3Rs) principle. Animal studies are reported
in compliance with the ARRIVE guidelines.
Two major series of rats A and B were employed in our study. In series A, rats with intact sensory
nerves were used whereas in rats of series B capsaicin was administered for three days in a dose of 25,
50 and 50 mg/kg (total dose: 125 mg/kg s.c.) two weeks before start of the study, to induce functional
ablation of afferent sensory nerves as described previously [11]. High dose of capsaicin has been
demonstrated previously to induce complete afferent sensory neurons ablation [8].
In the day of experiment, animals of both series A and B were randomly divided into appropriate
experimental groups, 4–5 animals each and were pretreated either with: (1) vehicle (DMSO/saline
(1:4); 1 mL/rat), (2) CORM-2 administered intragastrically (i.g.) in a gastroprotective dose of 5 mg/kg,
selected in our previous study [12] applied alone or combined with CGRP-α (10 µg/kg i.p.) [8], (3) zinc
protoporphyrin IX (ZnPP, 5 mg/kg i.g.), an inhibitor of HMOX [12], all applied 30 min before i.g.
application of 75% ethanol. In group 3, rats were pretreated with CORM-2 administered with or
without the combination with TRPV1 antagonist, capsazepine (5 mg/kg i.g.), before 75% ethanol
instillation [23].
To induce necrotic gastric damage in control experiments, the 75% ethanol was administered i.g.
to vehicle-pretreated control animals in the volume of 1.5 mL using orogastric tube, 30 min after
chemicals and drugs application, as reported by our group previously [12]. This model based on 75%
ethanol is known to induce necrotic gastric mucosal damage and to downregulate GBF [12].
All tested compounds were of analytical grade and were purchased from Sigma-Aldrich
(Schnelldorf, Germany).
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4.2. Measurement of GBF and Macroscopical and Microscopical Assessment of Ethanol-Induced Gastric Damage
One hour after 75% ethanol administration, animals were anesthetized with pentobarbital
(60 mg/kg i.p.), their abdomens were opened and GBF was determined in exposed stomachs by
laser flowmetry as described previously [11]. Briefly, the GBF was measured in oxyntic part of the
gastric mucosa not involving mucosal lesions. Average values of three measurements were determined
and expressed in mL/min per 100 g of gastric tissue. The area of ethanol-induced gastric damage in
each rat stomach was determined planimetrically and expressed in mm2 [11,12].
For histology, the gastric tissue sections were excised and fixed in 10% buffered formalin, pH 7.4.
Samples were dehydrated by passing them through a series of alcohols with incremental concentrations,
equilibrated in xylene for 10–15 min and embedded in paraffin; paraffin blocks were cut into about 4
µm sections using a microtome. The prepared specimens were stained with haematoxylin/eosin (H&E)
or alcian blue/periodic acid-Schiff/alcian blue (AB/PAS) and evaluated using a light microscope
(AxioVert A1, Carl Zeiss, Oberkochen, Germany) [24]. Digital documentation of histological slides was
obtained using above mentioned microsope equipped with automatic scanning table and ZEN Pro
2.3 software (Carl Zeiss, Oberkochen, Germany) to collect multiple photographs of each histological
sample and to stitch them into one picture; to obtain better quality of each picture, the background
was subtracted and unified as white.
Gastric mucosal biopsies (about 500 mg) were collected on ice, snap-frozen in liquid nitrogen and
stored at −80 ◦C for further analysis [25].
4.3. Determination of mRNA Level Fold Change for Heme Oxygenase Enzymes HMOX-1, HMOX-2, CGRP-α,
CGRP-β, iNOS, eNOS, nNOS, COX-1, COX-2 in Gastric Mucosa by Real Time Polymerase Chain Reaction (PCR)
Gastric mucosal mRNA expression for HMOX-1, HMOX-2, CGRP-α, CGRP-β, iNOS, eNOS,
nNOS, COX-1, and COX-2 was determined by semi-quantitative real time PCR, as described
previously [24].
Total RNA was isolated using commercially available kit with spin-columns (GeneMATRIX Universal
RNA Purification Kit, EURx, Gdansk, Poland) according to manufacturer protocol. Reversed trascription
to cDNA was performed using PrimeScript™ RT Master Mix (Perfect Real Time) (Takara Bio Inc., Kyoto,
Japan). RNA concentration was measured using Qubit 4 Fluorometer (Thermo Fisher Scientific, Waltham,
MA, USA). RT was normalized for each reaction regarding total RNA concentration to obtain the same
value (1 µg) for each sample. Results obtained for RNA samples isolated from healthy (intact) gastric
mucosa and transcribed to cDNA were further used as reference control during calculations.
Fold change for HMOX-1, HMOX-2, CGRP-α, iNOS, COX-1, COX-2, β-actin mRNA
levels was determined using specific primers [11,24–26]. Succinate dehydrogenase complex,
subunit A (SDHA) as reference gene was determined using 5’-TCCTTCCCACTGTGCATTACAA-3’
forward and 5’-CGTACAGACCAGGCACAATCTG-3’ reverse primers. CGRP-β was determined
using 5’-GAGGTGTGGTGAAGGACAAC-3’ forward and 5’-CAACTTTATGTAACCTTCTTCCTGG-3’
reverse primers. eNOS was determined using 5’-CCTGGCAGCCCTAAGACCTA-3’ forward
and 5’-GACGCTGGTTGCCATAGTGA-3’ reverse primers. nNOS was determined using
5’-ACCATCGTTGACCACCACTC-3’ forward and 5’-GACATGGGAGGCACAATCCA-3’ reverse
primers. SDHA and β-actin were used as reference genes.
The real time PCR was conducted using thermal cycler Quant Studio 3 (Thermo Fisher Scientific,
Waltham, MA, USA) and SYBR Green I dye including kit (SG qPCR Master Mix (2×), EURx, Gdansk,
Poland). The same amount of cDNA per each well was used to maintain the same PCR reaction
efficiency in all analyzed samples. After reaction, melting curve for each sample, its technical replicates
and for appropriate negative control were analyzed to exclude the data derived from potentially
unintended products. Results were analyzed using the −∆∆Ct method [12,27].
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4.4. Analysis of Protein Expression of HMOX-1, TRPV1 and β-actin in Gastric Mucosa by Western Blot
Protein expressions for HMOX-1, TRPV1, and β-actin in gastric mucosa were determined using
western blot as described in our previous studies [24,25]. Briefly, rabbit monoclonal anti-HMOX-1
(ab68477, Abcam, Cambridge, UK) in dilution of 1:2000, mouse monoclonal anti-TRPV1 (ab203103,
Abcam) in dilution of 1:1000, mouse monoclonal anti-β-actin (3700S, Cell Signaling Technology,
Danvers, MA, USA) in dilution of 1:1000 were used as primary antibodies. Protein expression
was visualized using horseradish peroxidase-linked secondary anti-rabbit IgG antibody (7074, Cell
Signaling Technology) or anti-mouse IgG antibody (7076, Cell Signaling Technology) in dilution of
1:2000 where appropriate. All primary and secondary antibodies were diluted in 5% non-fat milk.
Chemiluminescence was developed using WesternSure® ECL Substrate (LI-COR, Lincoln, NE,
USA) or WesternBright Quantum (Advansta, Menlo Park, CA, USA) and was measured using C-DiGit®
Blot Scanner (LI-COR). The intensity of bands was determined and analysed using Image Studio 4.0
software (LI-COR). The expression of each protein of interest was determined using 5 samples per
experimental group and obtained values were normalized to the expression of β-actin as loading
control [24].
HMOX-1 is known to exert time-dependent discrepancies between mRNA and protein levels in
damaged gastric mucosa [12]. While TRPV1 is a crucial receptor for afferent neurons activity and the
main aim of this study [6,7,11]. Therefore, we investigated those two targets on protein level. Other
abovementioned targets were measured on mRNA level because majority of them were previously
considered as the markers of gastric damage induced by ethanol or other noxious factors and we
aimed to show how CORM-2 and capsaicin-denervation affects their mRNA profile [11,12,24,25].
4.5. Statistical Analysis
Results were analyzed using GraphPad Prism 5.0 software (GraphPad Software, La Jolla, CA,
USA). Results are presented as mean ± SEM. Statistical analysis was conducted using Student’s t-test
or ANOVA with Dunnett’s Multiple Comparison post hoc test if more than two experimental groups
were compared. The group size for each experimental group was of n = 4 or 5. p < 0.05 was considered
as statistically significant.
5. Conclusions
Taken together, we conclude that CO released from CORM-2 attenuated ethanol-induced gastric
mucosal lesions in rats with intact sensory nerves and in those with functional ablation of afferent
sensory nerves induced by capsaicin. This militates against the possible mediation of this CO-induced
gastroprotection by the stimulation of sensory nerve activity by this gaseous molecule despite the fact
that an increase in expression of TRPV1 protein and CGRP-α mRNA expression in gastric mucosa of
CO-pretreated animals has been observed. It is possible that besides NO as manifested by an increase
in eNOS expression and anti-inflammatory activity of CO as documented by the fall in COX-2 and
iNOS expression in rats with and without sensory denervation, the TRPV1/CGRP-α system can be
involved in gastric hyperemia associated with this protection induced by CO released from its donor,
CORM-2. Exogenous CO may increase blood flow directly or via nitric oxide (NO) production from
eNOS and nNOS. However, the mechanism of CO-dependent gastroprotection and vasorelaxation
observed in the stomach injured by ethanol seems to be more complex and the role of afferent sensory
fibers activity in this beneficial effect of CO in gastroprotection against noxious agents including
ethanol warrants further investigation.
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